-Search query
-Search result
Showing 1 - 50 of 324 items for (author: li & cp)

EMDB-61131: 
Cryo-EM structure of aPlexinA1-19-43 Fab in complex with PlexinA1 dimer
Method: single particle / : Tian H, Fung CP

EMDB-53247: 
Tau Paired Helical Filaments using PAD12 for seeding in primary mouse neurons
Method: helical / : Lovestam S, Scheres SHW

EMDB-53461: 
Tau (297-391) assembled in the presence of CuCl2
Method: helical / : Lovestam S, Scheres SHW

EMDB-53462: 
Tau(297-408 S396D S400D T403D S404D) head to head fold type 1
Method: helical / : Lovestam S, Scheres SHW

EMDB-53463: 
Tau(297-391) filaments PHF fold
Method: helical / : Lovestam S, Scheres SHW

EMDB-53464: 
Tau(297-408 S396D S400D T403D S404D) head to head fold type 2
Method: helical / : Lovestam S, Scheres SHW

EMDB-62800: 
Cryo-EM structure of SARS-CoV-2 S-BQ.1 in complex with Ace2 constituent map 1
Method: single particle / : Hsu HF, Wu MH, Chang YC, Hsu STD

EMDB-62810: 
Cryo-EM structure of SARS-CoV-2 S-BQ.1 in complex with ACE2 constituent map 2
Method: single particle / : Hsu HF, Wu MH, Chang YC, Hsu STD

EMDB-71531: 
Angiopoietin-2 in complex with engineered conformationally rigid Fab 5A12.6DS, used for comparison with Fab 5A12.WT
Method: single particle / : Kung J, Johnson MC, Tegunov D, Jao CC, Wu P, Oh A, Lin M, Daria JM, Koth CM, Arthur CP, Rohou A, Sudhamsu J

EMDB-71532: 
Angiopoietin-2 in complex with Fab 5A12.WT, used for comparison with Fab 5A12.6DS
Method: single particle / : Kung J, Johnson MC, Tegunov D, Jao CC, Wu P, Oh A, Lin M, Daria JM, Koth CM, Arthur CP, Rohou A, Sudhamsu J

EMDB-70340: 
FH_302_07 Fab in complex with BG505 MD39.3 SOSIP (negative stain)
Method: single particle / : Lee WH, Ozorowski G, Ward AB

EMDB-70341: 
FH_302_14 Fab in complex with BG505 MD39.3 SOSIP (negative stain)
Method: single particle / : Lee WH, Ozorowski G, Ward AB

EMDB-70342: 
FH_302_23 Fab in complex with BG505 MD39.3 SOSIP (negative stain)
Method: single particle / : Lee WH, Ozorowski G, Ward AB

EMDB-70343: 
BG505 MD39.3-CC5 SOSIP in complex with V1V3 epitope polyclonal Fabs isolated from HVTN302 human trial after dose 3 of mRNA-gp151-CD4KO immunization
Method: single particle / : Lee WH, Ozorowski G, Ward AB

EMDB-70344: 
BG505 MD39.3-CC5 SOSIP in complex with gp41-base epitope polyclonal Fabs isolated from HVTN302 human trial after dose 3 of mRNA-gp151-CD4KO immunization
Method: single particle / : Lee WH, Ozorowski G, Ward AB

EMDB-70345: 
BG505 MD39.3-CC5 SOSIP in complex with C3V5 epitope polyclonal Fabs isolated from HVTN302 human trial after dose 3 of mRNA-gp151-CD4KO immunization
Method: single particle / : Lee WH, Ozorowski G, Ward AB

EMDB-51248: 
NME1 94-Phosphoserine
Method: single particle / : Roderer D, Schoepf F, Fiedler D, Celik A

EMDB-51250: 
NME1 94-Diphosphoserine
Method: single particle / : Roderer D, Schoepf F, Fiedler D, Celik A

EMDB-51251: 
NME1 94-Oligophosphoserine
Method: single particle / : Roderer D, Schoepf F, Fiedler D, Celik A

EMDB-52210: 
TRPML1 in complex with compound 2
Method: single particle / : Reeks J, Mahajan P, Clark M, Cowan SR, Di Daniel E, Earl CP, Fisher S, Holvey RS, Jackson SM, Lloyd-Evans E, Morgillo CM, Mortenson PN, O'Reilly M, Richardson CJ, Schopf P, Tams DM, Waller-Evans H, Ward SE, Whibley S, Williams PA, Johnson CN

EMDB-52211: 
TRPML1 in complex with compound 5
Method: single particle / : Reeks J, Mahajan P, Clark M, Cowan SR, Di Daniel E, Earl CP, Fisher S, Holvey RS, Jackson SM, Lloyd-Evans E, Morgillo CM, Mortenson PN, O'Reilly M, Richardson CJ, Schopf P, Tams DM, Waller-Evans H, Ward SE, Whibley S, Williams PA, Johnson CN

EMDB-52242: 
TRPML1 in complex with compound 1a
Method: single particle / : Reeks J, Mahajan P, Clark M, Cowan SR, Di Daniel E, Earl CP, Fisher S, Holvey RS, Jackson SM, Lloyd-Evans E, Morgillo CM, Mortenson PN, O'Reilly M, Richardson CJ, Schopf P, Tams DM, Waller-Evans H, Ward SE, Whibley S, Williams PA, Johnson CN

EMDB-52243: 
TRPML1 in complex with compound 3
Method: single particle / : Reeks J, Mahajan P, Clark M, Cowan SR, Di Daniel E, Earl CP, Fisher S, Holvey RS, Jackson SM, Lloyd-Evans E, Morgillo CM, Mortenson PN, O'Reilly M, Richardson CJ, Schopf P, Tams DM, Waller-Evans H, Ward SE, Whibley S, Williams PA, Johnson CN

EMDB-52245: 
TRPML1 in complex with compound 4a
Method: single particle / : Reeks J, Mahajan P, Clark M, Cowan SR, Di Daniel E, Earl CP, Fisher S, Holvey RS, Jackson SM, Lloyd-Evans E, Morgillo CM, Mortenson PN, O'Reilly M, Richardson CJ, Schopf P, Tams DM, Waller-Evans H, Ward SE, Whibley S, Williams PA, Johnson CN

EMDB-52246: 
TRPML1 in complex with compound 8
Method: single particle / : Reeks J, Mahajan P, Clark M, Cowan SR, Di Daniel E, Earl CP, Fisher S, Holvey RS, Jackson SM, Lloyd-Evans E, Morgillo CM, Mortenson PN, O'Reilly M, Richardson CJ, Schopf P, Tams DM, Waller-Evans H, Ward SE, Whibley S, Williams PA, Johnson CN

EMDB-52248: 
TRPML1 in complex with compound 9a
Method: single particle / : Reeks J, Mahajan P, Clark M, Cowan SR, Di Daniel E, Earl CP, Fisher S, Holvey RS, Jackson SM, Lloyd-Evans E, Morgillo CM, Mortenson PN, O'Reilly M, Richardson CJ, Schopf P, Tams DM, Waller-Evans H, Ward SE, Whibley S, Williams PA, Johnson CN

EMDB-52249: 
TRPML1 in complex with compound 10
Method: single particle / : Reeks J, Mahajan P, Clark M, Cowan SR, Di Daniel E, Earl CP, Fisher S, Holvey RS, Jackson SM, Lloyd-Evans E, Morgillo CM, Mortenson PN, O'Reilly M, Richardson CJ, Schopf P, Tams DM, Waller-Evans H, Ward SE, Whibley S, Williams PA, Johnson CN

EMDB-52250: 
TRPML1 in complex with compound 11
Method: single particle / : Reeks J, Mahajan P, Clark M, Cowan SR, Di Daniel E, Earl CP, Fisher S, Holvey RS, Jackson SM, Lloyd-Evans E, Morgillo CM, Mortenson PN, O'Reilly M, Richardson CJ, Schopf P, Tams DM, Waller-Evans H, Ward SE, Whibley S, Williams PA, Johnson CN

EMDB-52251: 
TRPML1 in complex with compound 13
Method: single particle / : Reeks J, Mahajan P, Clark M, Cowan SR, Di Daniel E, Earl CP, Fisher S, Holvey RS, Jackson SM, Lloyd-Evans E, Morgillo CM, Mortenson PN, O'Reilly M, Richardson CJ, Schopf P, Tams DM, Waller-Evans H, Ward SE, Whibley S, Williams PA, Johnson CN

EMDB-48575: 
G002-293-0536 Fab in complex with 001428_T278M_L14 SOSIP and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48591: 
G002-480-0546 Fab in complex with V703-0537_T278M_L14 SOSIP and BG18 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9msd: 
G002-293-0536 Fab in complex with 001428_T278M_L14 SOSIP and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9msy: 
G002-480-0546 Fab in complex with V703-0537_T278M_L14 SOSIP and BG18 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48283: 
61-12A01 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48286: 
206-3G08 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48287: 
206-9C09 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48290: 
273-4D01 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48291: 
253-7A03 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-70490: 
BG505 GT1.1 SOSIP in complex with gp41-base epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70491: 
BG505 GT1.1 SOSIP in complex with V1V2V3 epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70492: 
BG505 GT1.1 SOSIP in complex with C3V5 epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70493: 
BG505 GT1.1 SOSIP in complex with CD4bs epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70494: 
BG505 GT1.1 SOSIP in complex with gp41 glycan hole epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70495: 
BG505 GT1.1 SOSIP in complex with gp41 fusion peptide epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

PDB-9mi0: 
61-12A01 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mia: 
206-3G08 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mib: 
206-9C09 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mih: 
273-4D01 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mii: 
253-7A03 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-44895: 
Cryo-EM structure of extracellular tube from Microcystis Aeruginosa pcc 7806SL
Method: helical / : Petersen HA, Ricca JG, Louda JW, Wang F
Pages:
Movie
Controller
Structure viewers
About EMN search



wwPDB to switch to version 3 of the EMDB data model
